NCT05208047 2026-02-04(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal TumorsCogent Biosciences, Inc.Phase 3 Active not recruiting442 enrolled